2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Intrexon Corp | 10% Owner | 17,736,767 | Jan 3, 2014 |
| Cooper Laurence James Neil | CEO | 1,799,280 | Jan 6, 2021 |
| Boyle Kevin S. Sr. | CEO | 798,236 | Sep 5, 2023 |
| Hogue Dale Curtis Jr. | — | 600,000 | Jan 23, 2024 |
| McInerney Timothy | Director | 372,120 | Jan 2, 2015 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Jan 15, 2026 | Jerman Michael Allen | Director | Neutral | 90.0 | +5,406 | 129.24% | ✗ | - |
| Jan 12, 2026 | Jan 15, 2026 | Postma Robert W | Director | Neutral | 85.0 | +5,622 | 5.58% | ✗ | - |
| Jan 12, 2026 | Jan 15, 2026 | Vieser Jaime | Director | Neutral | 90.0 | +5,839 | 13.87% | ✗ | - |
| Nov 21, 2025 | Nov 26, 2025 | Vieser Jaime | Director | Neutral | 90.0 | +5,340 | 14.53% | ✗ | - |
| Nov 21, 2025 | Nov 26, 2025 | Postma Robert W | Director | Neutral | 85.0 | +5,142 | 7.74% | ✗ | - |
| Nov 21, 2025 | Nov 26, 2025 | Jerman Michael Allen | Director | Neutral | 90.0 | +4,183 | 100.00% | ✗ | - |
| Aug 18, 2025 | Aug 20, 2025 | Groenewald Ferdinand | President | Neutral | 90.0 | +10,775 | 100.00% | ✗ | - |
| Aug 18, 2025 | Aug 20, 2025 | Weis Holger | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 15, 2025 | Jul 17, 2025 | Jerman Michael Allen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 17, 2025 | Jerman Michael Allen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 3, 2025 | Jul 7, 2025 | Postma Robert W | Director | Neutral | 82.5 | +4,050 | 4.43% | ✗ | - |
| Jul 3, 2025 | Jul 7, 2025 | Vieser Jaime | Director | Neutral | 90.0 | +3,400 | 10.19% | ✗ | - |
| Jul 2, 2025 | Jul 7, 2025 | Weis Holger | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 24, 2025 | Jun 26, 2025 | Vieser Jaime | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 13, 2025 | Jun 26, 2025 | Postma Robert W | Director | Neutral | 90.0 | +20,804 | 49.97% | ✗ | - |
| Apr 13, 2025 | Apr 15, 2025 | Postma Robert W | Director | Neutral | 90.0 | +20,804 | 49.97% | ✗ | - |
| Apr 13, 2025 | Apr 15, 2025 | Weis Holger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 13, 2025 | Apr 15, 2025 | Vieser Jaime | Director | Neutral | 90.0 | +17,465 | 67.45% | ✗ | - |
| Mar 29, 2025 | Apr 1, 2025 | Hogue Dale Curtis Jr. | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 29, 2025 | Apr 1, 2025 | Lackey Melinda | Legal & Administration | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 29, 2025 | Apr 1, 2025 | Groenewald Ferdinand | VP, Finance | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 31, 2024 | Jan 3, 2025 | Vieser Jaime | Director | Sell | 27.5 | -3,000 | -10.38% | ✗ | $6K |
| Aug 14, 2024 | Aug 16, 2024 | Groenewald Ferdinand | VP, Finance | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 14, 2024 | Aug 16, 2024 | Lackey Melinda | Legal & Administration | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 10, 2024 | Weis Holger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 10, 2024 | Vieser Jaime | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 10, 2024 | Postma Robert W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 10, 2024 | Hofmeister Robert | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 28, 2024 | Groenewald Ferdinand | President | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 20, 2024 | Jan 23, 2024 | Hogue Dale Curtis Jr. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 29, 2023 | Jan 3, 2024 | Hogue Dale Curtis Jr. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 3, 2024 | Hogue Dale Curtis Jr. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 1, 2023 | Sep 5, 2023 | Boyle Kevin S. Sr. | CEO | Sell | 33.8 | -68,014 | -7.85% | ✓ | $9.5K |
| Jun 6, 2023 | Jun 8, 2023 | Postma Robert W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2023 | Jun 8, 2023 | Hofmeister Robert | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2023 | Jun 8, 2023 | Thistle Mary | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2023 | Jun 8, 2023 | Huang James | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2023 | Jun 8, 2023 | Vieser Jaime | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2023 | Jun 8, 2023 | Weis Holger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 30, 2023 | Apr 19, 2023 | Hofmeister Robert | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 19, 2023 | Hofmeister Robert | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 15, 2023 | Mar 17, 2023 | Srivastava Abhishek K | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 15, 2023 | Mar 17, 2023 | Wong Michael | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 15, 2023 | Mar 17, 2023 | Boyle Kevin S. Sr. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 15, 2023 | Mar 17, 2023 | Deniger Drew | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 15, 2023 | Mar 17, 2023 | Lackey Melinda | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 29, 2022 | Dec 1, 2022 | Postma Robert W | Director | Buy | 97.5 | +750,000 | 13.65% | ✗ | $487.5K |
| Nov 29, 2022 | Dec 1, 2022 | Vieser Jaime | Director | Buy | 97.5 | +1,250,000 | 116.79% | ✗ | $812.5K |
| Sep 15, 2022 | Sep 19, 2022 | Deniger Drew | VP, Research and Development | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 15, 2022 | Sep 19, 2022 | Srivastava Abhishek K | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 15, 2022 | Sep 19, 2022 | Wong Michael | VP, Finance | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 15, 2022 | Sep 19, 2022 | Lackey Melinda | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 30, 2022 | Sep 1, 2022 | Boyle Kevin S. Sr. | CEO | Sell | 46.3 | -18,750 | -2.12% | ✗ | $45.2K |
| Aug 12, 2022 | Aug 16, 2022 | Srivastava Abhishek K | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2022 | Srivastava Abhishek K | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 22, 2022 | Jun 24, 2022 | Thistle Mary | Director | Neutral | 90.0 | +40,000 | 800.00% | ✗ | - |
| Jun 22, 2022 | Jun 24, 2022 | Huang James | Director | Neutral | 90.0 | +80,000 | 73.85% | ✗ | - |
| Jun 22, 2022 | Jun 24, 2022 | Postma Robert W | Director | Neutral | 67.5 | +40,000 | 0.73% | ✗ | - |
| Jun 22, 2022 | Jun 24, 2022 | Thistle Mary | Director | Neutral | 90.0 | +40,000 | 800.00% | ✗ | - |
| Jun 22, 2022 | Jun 24, 2022 | Huang James | Director | Neutral | 90.0 | +80,000 | 73.85% | ✗ | - |
| Jun 22, 2022 | Jun 24, 2022 | Postma Robert W | Director | Neutral | 67.5 | +40,000 | 0.73% | ✗ | - |
| Jun 22, 2022 | Jun 24, 2022 | Vieser Jaime | Director | Neutral | 82.5 | +40,000 | 3.88% | ✗ | - |
| Jun 22, 2022 | Jun 24, 2022 | Bowden Christopher | Director | Neutral | 90.0 | +40,000 | 959.92% | ✗ | - |
| Jun 22, 2022 | Jun 24, 2022 | Weis Holger | Director | Neutral | 90.0 | +40,000 | 28.25% | ✗ | - |
| Apr 8, 2022 | Deniger Drew | VP, Research & Development | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 30, 2022 | Apr 1, 2022 | Boyle Kevin S. Sr. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 30, 2022 | Apr 1, 2022 | De Groot Eleanor | EVP, Operations | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 22, 2021 | Dec 27, 2021 | De Groot Eleanor | EVP, Operations | Sell | 32.5 | -20,132 | -7.83% | ✓ | $25.6K |
| Dec 10, 2021 | Dec 13, 2021 | Lackey Melinda | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 9, 2021 | Lackey Melinda | President | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 29, 2021 | Wong Michael | President | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 16, 2021 | Nov 17, 2021 | Boyle Kevin S. Sr. | CEO | Buy | 78.8 | +10,000 | 1.14% | ✗ | $14K |
| Sep 29, 2021 | Oct 4, 2021 | Vieser Jaime | Director | Buy | 95.0 | +100,000 | 10.75% | ✗ | $191K |
| Sep 2, 2021 | Sep 3, 2021 | Hagen Heidi | Director | Buy | 91.3 | +23,770 | 19.46% | ✗ | $41.8K |
| Sep 1, 2021 | Sep 3, 2021 | Weis Holger | Director | Buy | 95.0 | +50,000 | 54.58% | ✗ | $91.5K |
| Sep 2, 2021 | Sep 3, 2021 | Postma Robert W | Director | Buy | 82.5 | +75,000 | 1.39% | ✗ | $129.8K |
| Sep 1, 2021 | Sep 3, 2021 | Huang James | Director | Buy | 95.0 | +100,000 | 1200.05% | ✗ | $171K |
| Aug 30, 2021 | Aug 31, 2021 | Boyle Kevin S. Sr. | CEO | Neutral | 90.0 | +875,000 | 100.00% | ✗ | - |
| Aug 31, 2021 | Boyle Kevin S. Sr. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 17, 2021 | May 19, 2021 | Baffa Raffaele | Chief Medical Officer | Neutral | 90.0 | +80,645 | 40.32% | ✗ | - |
| Mar 4, 2021 | May 6, 2021 | Weis Holger | Director | Neutral | 82.5 | +4,167 | 4.77% | ✗ | - |
| Mar 4, 2021 | May 6, 2021 | Vieser Jaime | Director | Neutral | 60.0 | +4,167 | 0.45% | ✗ | - |
| Mar 4, 2021 | May 6, 2021 | Thistle Mary | Director | Neutral | 90.0 | +5,000 | 100.00% | ✗ | - |
| Mar 4, 2021 | May 6, 2021 | Postma Robert W | Director | Neutral | 47.5 | +2,500 | 0.05% | ✗ | - |
| Mar 4, 2021 | May 6, 2021 | Huang James | Director | Neutral | 90.0 | +8,333 | 100.00% | ✗ | - |
| Mar 4, 2021 | May 6, 2021 | BUCHI J KEVIN | Director | Neutral | 90.0 | +4,167 | 100.00% | ✗ | - |
| Mar 4, 2021 | May 6, 2021 | Bowden Christopher | Director | Neutral | 90.0 | +4,167 | 100.00% | ✗ | - |
| Mar 31, 2021 | Baffa Raffaele | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 22, 2021 | Weis Holger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 22, 2021 | Vieser Jaime | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 22, 2021 | Postma Robert W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 4, 2021 | Mar 8, 2021 | Buck Jill | EVP, GM Gene Therapy | Neutral | 90.0 | +31,500 | 15.79% | ✗ | - |
| Mar 4, 2021 | Mar 8, 2021 | Hadfield Robert | Chief Legal Officer and Sec. | Neutral | 90.0 | +43,500 | 32.63% | ✗ | - |
| Mar 4, 2021 | Mar 8, 2021 | Hagen Heidi | CEO | Neutral | 90.0 | +90,000 | 280.21% | ✗ | - |
| Mar 4, 2021 | Mar 8, 2021 | De Groot Eleanor | EVP, GM Cell Therapy | Neutral | 90.0 | +50,825 | 24.62% | ✗ | - |
| Feb 26, 2021 | Cunningham Timothy M. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 8, 2021 | Jan 12, 2021 | Buck Jill | EVP, GM Gene Therapy | Sell | 25.0 | -27,894 | -12.27% | ✓ | $87K |
| Jan 8, 2021 | Jan 12, 2021 | Lafond Kevin G | SVP, Treasurer & CAO | Sell | 15.0 | -18,020 | -21.98% | ✓ | $55.7K |
| Jan 8, 2021 | Jan 12, 2021 | Hadfield Robert | General Counsel and Secretary | Sell | 20.0 | -26,500 | -16.58% | ✓ | $82.7K |
| Jan 4, 2021 | Jan 6, 2021 | De Groot Eleanor | EVP, GM Cell Therapy | Sell | 28.8 | -21,620 | -9.48% | ✓ | $58.8K |